CClinicalTrials.gg
RecruitingNCT06467916Updated Apr 24, 2025

The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home

An interventional study of Behavioral Treatment in Perinatal Mental Health, sponsored by University of Colorado, Denver. Recruiting at 2 sites in United States. Per ClinicalTrials.gov, last updated 2025-04-24.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Sex
All
01

Study summary

The objective of this study is to develop and pilot test a telehealth-based mental health screening and engagement program that supports parents as their infants transition home from the NICU. The program will use a stepped-care approach to screen parents for depression, anxiety, and PTSD; provide a brief behavioral intervention to those who screen as having at least a low risk of these conditions; and provide a warm hand-off to community mental health services for those at medium to high risk.

02

Conditions studied

  • Perinatal Mental Health

Keywords

  • neonatal intensive care unit
  • perinatal mental health
  • perinatal depression
  • perinatal anxiety
  • posttraumatic stress disorder
03

In context

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,499 studies on the registry; 315 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 89 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • NICU parents: Participants will be parents of currently hospitalized preterm infants from either the OHSU NICU or the UCH NICU. We will include parents of live preterm infants who have been admitted in the NICU for at least 2 weeks. Parents must speak English or Spanish. Parents can be of any age.
  • NICU stakeholders: Participants will be stakeholders from either the OHSU NICU or the UCH NICU. Stakeholders will be social workers, mental health providers responsible for providing more intensive mental health support for NICU parents, nurses, neonatologists, and hospital administrators.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Intervention

    anticipatory guidance, brief behavioral intervention, or referral to community mental health provider

    Behavioral: Behavioral Treatment

  • No intervention
    Control

    usual care

Interventions

  • BehavioralBehavioral Treatment

    anticipatory guidance, brief behavioral intervention, or referral to community mental health provider

06

What researchers measure

Primary outcomes

  1. Mental health self-efficacy scale

    Mental health self-efficacy

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

Secondary outcomes

  1. City Mental Illness Stigma Scale

    Mental illness stigma

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

  2. Parenting Sense of Self Confidence Scale

    Parenting self-efficacy

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

Other outcomes

  1. Edinburgh Postnatal Depression Scale (EDPS)

    Perinatal depression

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

  2. GAD-7

    Anxiety

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

  3. Post-Traumatic Stress Disorder Questionnaire (PPQ)

    PTSD

    Time frame: ~2 weeks prior to discharge; 2 weeks post-discharge; 6 weeks post-discharge

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Project data and materials will be administered in accordance with both participating institutional and NIH policies, including the NICH Data Sharing Policy and Implementation Guidance of March 5, 2003. Depending on such policies, materials may be transferred to others under the terms of material transfer agreement. Data, including survey instruments and datasets, will be available approximately one year after study completion. Researchers can contact the research staff to request access to datasets and support for their use. Publication of data shall occur during the project, if appropriate, or at the end of the project, consistent with normal scientific practices. The final locked dataset will be stripped of all participant identifiers. This dataset will be available to the nonprofit community for noncommercial uses provided that a data-sharing agreement is reached and that the original creators of the dataset are able to collaborate in all secondary data analysis.

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06467916
Lead sponsor
University of Colorado, Denver
Collaborators
Oregon Health and Science University, National Institute of Mental Health (NIMH)
Responsible party
Sponsor
First posted
Jun 21, 2024
Start date
Apr 22, 2025 (estimated)
Primary completion
Apr 1, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Apr 24, 2025

Study contacts

Susanne Klawetter, PhD
Contact
susanne.klawetter@cuanschutz.edu
303-724-1646
Sunah S Hwang, MD, PhD, MPH/MSPH
Contact
sunah.hwang@childrenscolorado.org
720-848-0000

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion